Composition for Treating Uterine Fibroid (SB-UF)
NCT: NCT04762316 · COMPLETED
Brief Summary
Pregnenolone \& Pyridoxal Phosphate SB-UF for treating uterine fibroids in women's pregnancies to lose the size of fibroids and to dissolve fibroids. Uterine fibroids are a very common finding in women pregnancy of reproductive age, fibroids fast grow in the first trimester of pregnancy. SB-UF against the rapid growth of fibroids under the influence of hormones during pregnancy. Use SB-UF to think about regulating stable Oestrogen levels and dissolving fibroids. This is a substantial insight into disease pathogenesis, with a clear path toward clinical application, which would lead to a substantial advance and perfection in management or public health policy.
Frequently Asked Questions
What is Composition for Treating Uterine Fibroid (SB-UF)?
Composition for Treating Uterine Fibroid (SB-UF) is a clinical trial registered under NCT04762316. Current status: COMPLETED.
What is the status of NCT04762316?
The current status of NCT04762316 (Composition for Treating Uterine Fibroid (SB-UF)) is: COMPLETED.
When did Composition for Treating Uterine Fibroid (SB-UF) start?
Composition for Treating Uterine Fibroid (SB-UF) started on 2019-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.